Mo Jain

Company: Sapient Bioanalytics

Job title: Founder & Chief Executive Officer

Seminars:

Next-Generation Multi-Omics to Identify Dynamic Biomarkers for Neurodegenerative Disease 2:00 pm

How next-generation mass spectrometry technologies are enabling large-scale, multi-omics biomarker discovery – including metabolites, lipids, and proteins Using precision-guided approaches for targeted multi-omic measures of established Alzheimer’s and Parkinson’s biomarkers Leveraging ‘discovery’ mass spectrometry to elucidate novel biomarkers of neurodegeneration and CNS drug responseRead more

day: Translational Track Day 2 PM